Device Development

Latest News

FDA Approves Johnson & Johnson’s VARIPULSE Pulsed Field Ablation Platform for AFib
FDA Approves Johnson & Johnson’s VARIPULSE Pulsed Field Ablation Platform for AFib

November 11th 2024

The approval is based on results from the admIRE study, which showed 100% of atrial fibrillation patients achieved acute procedural success.

Image Credit: Adobe Stock Images/RareStock
Synchron Advances Efforts to Develop Brain-Computer Interface

February 13th 2024

stock.adobe.com
XtalPi Inc. Announces New Intelligent Automation Brand

August 28th 2023

stock.adobe.com
Neurolief Reveals Data on Wearable Digital Therapeutic for Migraine Treatment and Prevention

June 20th 2023

CDMOs Show Strong Growth in 2023 US MedTech Contract Manufacturing Report

March 8th 2023

Video Interviews
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.